...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood.
【24h】

The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood.

机译:EP3激动剂舒普司通,而不是前列腺素E2增强人血中的血小板聚集。

获取原文
获取原文并翻译 | 示例
           

摘要

Dear Sirs,Acute coroinuy syndromes, myocardial infarction and ischaemic stroke are leading causes of mortality and morbidity. Atherosclerosis, the basis for these diseases, has an important inflammatory component, and macrophages accumulating in atherosclerotic arteries produce prostaglandin E_2 (PGE_2), a major inflammatory mediator (1-3). Recently, it has been reported in mice that PGE_2 accumulating in inflammatory atherosclerotic lesions might contribute to atherothrombosis after plaque rupture (4).
机译:尊敬的先生们:急性冠心病综合征,心肌梗塞和缺血性中风是导致死亡和发病的主要原因。动脉粥样硬化是这些疾病的基础,具有重要的炎症成分,在动脉粥样硬化动脉中积聚的巨噬细胞会产生主要的炎症介质前列腺素E_2(PGE_2)(1-3)。最近,据报道,在小鼠中,在炎症性动脉粥样硬化病变中蓄积的PGE_2可能有助于斑块破裂后的动脉粥样硬化。(4)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号